Maintenance of normal mineral ion homeostasis is crucial for many biological activities, including proper mineralization of the skeleton. Parathyroid hormone (PTH), Klotho, and FGF23 have been shown to act as key regulators of serum calcium and phosphate homeostasis through a complex feedback mechanism. The phenotypes of Fgf23−/− and Klotho−/− (Kl−/−) mice are very similar and include hypercalcemia, hyperphosphatemia, hypervitaminosis D, suppressed PTH levels, and severe osteomalacia/osteoidosis. We recently reported that complete ablation of PTH from Fgf23−/− mice ameliorated the phenotype in Fgf23−/−/PTH−/− mice by suppressing serum vitamin D and calcium levels. The severe osteomalacia in Fgf23−/− mice, however, persisted, suggesting that a different mechanism is responsible for this mineralization defect. In the current study, we demonstrate that deletion of PTH from Kl−/− (Kl−/−/PTH−/− or DKO) mice corrects the abnormal skeletal phenotype. Bone turnover markers are restored to wild-type levels; and, more importantly, the skeletal mineralization defect is completely rescued in Kl−/−/PTH−/− mice. Interestingly, the correction of the osteomalacia is accompanied by a reduction in the high levels of osteopontin (Opn) in bone and serum. Such a reduction in Opn levels could not be observed in Fgf23−/−/PTH−/− mice, and these mice showed sustained osteomalacia. This significant in vivo finding is corroborated by in vitro studies using calvarial osteoblast cultures that show normalized Opn expression and rescued mineralization in Kl−/−/PTH−/− mice. Moreover, continuous PTH infusion of Kl−/− mice significantly increased Opn levels and osteoid volume, and decreased trabecular bone volume. In summary, our results demonstrate for the first time that PTH directly impacts the mineralization disorders and skeletal deformities of Kl−/−, but not of Fgf23−/− mice, possibly by regulating Opn expression. These are significant new perceptions into the role of PTH in skeletal and disease processes and suggest FGF23-independent interactions of PTH with Klotho.
Vyšlo v časopise: Deletion of PTH Rescues Skeletal Abnormalities and High Osteopontin Levels in Mice. PLoS Genet 8(5): e32767. doi:10.1371/journal.pgen.1002726 Kategorie: Research Article prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002726
1. RenkemaKYAlexanderRTBindelsRJHoenderopJG 2008 Calcium and phosphate homeostasis: concerted interplay of new regulators. Ann Med 40 82 91
2. DussoASBrownAJSlatopolskyE 2005 Vitamin D. Am J Physiol Renal Physiol 289 F8 28
3. RazzaqueMSLanskeB 2007 The emerging role of the fibroblast growth factor-23-klotho axis in renal regulation of phosphate homeostasis. J Endocrinol 194 1 10
4. LanskeBRazzaqueMS 2007 Mineral metabolism and aging: the fibroblast growth factor 23 enigma. Curr Opin Nephrol Hypertens 16 311 318
5. LeeMPartridgeNC 2009 Parathyroid hormone signaling in bone and kidney. Curr Opin Nephrol Hypertens 18 298 302
6. LiSAWatanabeMYamadaHNagaiAKinutaM 2004 Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct Funct 29 91 99
7. MatsumuraYAizawaHShiraki-IidaTNagaiRKuro-oM 1998 Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun 242 626 630
8. Shiraki-IidaTAizawaHMatsumuraYSekineSIidaA 1998 Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett 424 6 10
9. UrakawaIYamazakiYShimadaTIijimaKHasegawaH 2006 Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature
10. SaitoHKusanoKKinosakiMItoHHirataM 2003 Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1alpha,25-dihydroxyvitamin D3 production. J Biol Chem 278 2206 2211
11. ShimadaTUrakawaIYamazakiYHasegawaHHinoR 2004 FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. Biochem Biophys Res Commun 314 409 414
12. ChangQHoefsSvan der KempAWTopalaCNBindelsRJ 2005 The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310 490 493
13. BjorklundPKrajisnikTAkerstromGWestinGLarssonTE 2008 Type I membrane klotho expression is decreased and inversely correlated to serum calcium in primary hyperparathyroidism. J Clin Endocrinol Metab 93 4152 4157
14. ImuraATsujiYMurataMMaedaRKubotaK 2007 alpha-Klotho as a regulator of calcium homeostasis. Science 316 1615 1618
15. Ben-DovIZGalitzerHLavi-MoshayoffVGoetzRKuro-oM 2007 The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117 4003 4008
16. KrajisnikTBjorklundPMarsellRLjunggrenOAkerstromG 2007 Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 195 125 131
17. SitaraDRazzaqueMSSt-ArnaudRHuangWTaguchiT 2006 Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol 169 2161 2170
18. SitaraDKimSRazzaqueMSBergwitzCTaguchiT 2008 Genetic evidence of serum phosphate-independent functions of FGF-23 on bone. PLoS Genet 4 e1000154 doi:10.1371/journal.pgen.1000154
19. RazzaqueMSSitaraDTaguchiTSt-ArnaudRLanskeB 2006 Premature ageing-like phenotype in fibroblast growth factor 23 null mice is a vitamin-D mediated process. The FASEB Journal 20 720 722
20. NakataniTSarrajBOhnishiMDensmoreMJTaguchiT 2009 In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis. Faseb J 23 433 441
21. NakataniTOhnishiMRazzaqueMS 2009 Inactivation of klotho function induces hyperphosphatemia even in presence of high serum fibroblast growth factor 23 levels in a genetically engineered hypophosphatemic (Hyp) mouse model. Faseb J 23 3702 3711
22. BrownsteinCAZhangJStillmanAEllisBTroianoN Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse. Endocrinology 151 492 501
23. YuanQSitaraDSatoTDensmoreMSaitoH 2011 PTH Ablation Ameliorates the Anomalies of Fgf23-Deficient Mice by Suppressing the Elevated Vitamin D and Calcium Levels. Endocrinology 152 4053 4061
24. WangHYoshikoYYamamotoRMinamizakiTKozaiK 2008 Overexpression of fibroblast growth factor 23 suppresses osteoblast differentiation and matrix mineralization in vitro. J Bone Miner Res 23 939 948
25. KurosuHOgawaYMiyoshiMYamamotoMNandiA 2006 Regulation of fibroblast growth factor-23 signaling by Klotho. J Biol Chem
26. TomiyamaKMaedaRUrakawaIYamazakiYTanakaT 2010 Relevant use of Klotho in FGF19 subfamily signaling system in vivo. Proc Natl Acad Sci U S A 107 1666 1671
27. RazzaqueMS 2009 The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol 5 611 619
28. RheeYBiviNFarrowELezcanoVPlotkinLI Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo. Bone 49 636 643
29. LiuHFergussonMMCastilhoRMLiuJCaoL 2007 Augmented Wnt signaling in a mammalian model of accelerated aging. Science 317 803 806
30. BrownsteinCAZhangJStillmanAEllisBTroianoN 2010 Increased bone volume and correction of HYP mouse hypophosphatemia in the Klotho/HYP mouse. Endocrinology 151 492 501
31. LuoGDucyPMcKeeMDPineroGJLoyerE 1997 Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386 78 81
32. SteitzSASpeerMYMcKeeMDLiawLAlmeidaM 2002 Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161 2035 2046
33. SuttamanatwongSFranceschiRTCarlsonAEGopalakrishnanR 2007 Regulation of matrix Gla protein by parathyroid hormone in MC3T3-E1 osteoblast-like cells involves protein kinase A and extracellular signal-regulated kinase pathways. J Cell Biochem 102 496 505
34. GopalakrishnanRSuttamanatwongSCarlsonAEFranceschiRT 2005 Role of matrix Gla protein in parathyroid hormone inhibition of osteoblast mineralization. Cells Tissues Organs 181 166 175
35. FosterBLNocitiFHJrSwansonECMatsa-DunnDBerryJE 2006 Regulation of cementoblast gene expression by inorganic phosphate in vitro. Calcif Tissue Int 78 103 112
36. JulienMKhoshniatSLacreusetteAGatiusMBozecA 2009 Phosphate-dependent regulation of MGP in osteoblasts: role of ERK1/2 and Fra-1. J Bone Miner Res 24 1856 1868
37. FatheraziSMatsa-DunnDFosterBLRutherfordRBSomermanMJ 2009 Phosphate regulates osteopontin gene transcription. J Dent Res 88 39 44
38. MiaoDHeBLanskeBBaiXYTongXK 2004 Skeletal abnormalities in Pth-null mice are influenced by dietary calcium. Endocrinology 145 2046 2053
39. McLeodMJ 1980 Differential staining of cartilage and bone in whole fetuses by alcian blue and alizarin red S. Teratology 22 299 301
40. YuanQSatoTDensmoreMSaitoHSchulerC 2011 Fgf23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH. J Bone Miner Res 26 2026 2035
41. LanskeBDivietiPKovacsCSPirroALandisWJ 1998 The parathyroid hormone (PTH)/PTH-related peptide receptor mediates actions of both ligands in murine bone. Endocrinology 139 5194 5204
Zvýšte si kvalifikáciu online z pohodlia domova
Nemáte účet? Registrujte sa
Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.
